Show news: from last 30 days (default), 60 days, 90 days, last visit or all

Glycopyrronium 1mg/5mL oral solution updated indications

14th March 2019

Glycopyrronium bromide 1mg/5mL oral solution (Colonis Pharma) is now authorized for the treatment of severe sialorrhoea in children and adolescents ≥ 3 years with chronic neurological disorders. Previously, only the Sialanar product (Glycopyrronium bromide 2mg/5mL) was authorized for this indication (see our news item).

Click here to view